NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
Read More- CID-103 is a potential best-in-class, anti-CD38 monoclonal antibody
- Phase 1 dose escalation study in Immune Thrombocytopenia (ITP) results and update
Demonstrated feasibility of effective DNA delivery with Company's xPhore™ nanoparticle technology
DNA delivery technology to be offered as GenePhore™ to biotech / pharma companies
Addressing large and growing market
Key Highlights:
Pivot Controller Line Validated: Manufacturing line has now been validated for human-use production in support of expected Q1 2026 market launch.
Pivot will be First Two-Part Tubeless Patch Pump: Pivot, a 3 milliliter removable patch pump, targets the $3 billion dollar market for adult "almost-pumpers" with its affordable, user-friendly, easy-to-learn design.
High-Volume Manufacturing Readiness: Modular Medical's scalable platform positions it to target a significant share of the insulin pump market.
Read More
This latest recognition adds to recent honors for bGen ZERO following winning Gold earlier this year in the Energy Storage and Management category from the Edison Awards and being named one of TIME magazine's Best Inventions of 2023 in the Green Energy Category
Read More
The show airs as sponsored programming and includes TV commercials for Laser Photonics, The Sustainable Green Team (OTC:SGTM), PetVivo Holdings, Inc. , and Synergy CHC Corp.
Read More
Highlights
Successful completion of due diligence by the Clean Elements Fund ("Clean Elements") confirming HMW's world-class status; $20 million placement to proceed with full and final settlement due by November.
RIGI incentive regime approved by the Argentine Government for the HMW Project, providing fiscal stability and significant long-term benefits.
Advancement of Phase 1 construction at Hombre Muerto West (HMW), including completion of Pond 4 design and progress on nano-filtration plant fabrication in Sydney.
No debt and strong cash position of approx. $11m with a further $10m in placement proceeds due in November.
Galan remains funded to complete Phase 1 construction and deliver first lithium chloride production in H1 2026.
Strategic expansion of Greenbushes South tenure.